The Emerging Drugs Network of Australia - Victoria Clinical Registry: A state-wide illicit substance surveillance and alert network.

early warning system illicit drugs novel psychoactive substances public health toxicosurveillance

Journal

Emergency medicine Australasia : EMA
ISSN: 1742-6723
Titre abrégé: Emerg Med Australas
Pays: Australia
ID NLM: 101199824

Informations de publication

Date de publication:
02 2023
Historique:
revised: 11 07 2022
received: 28 03 2022
accepted: 26 07 2022
pubmed: 3 9 2022
medline: 19 1 2023
entrez: 2 9 2022
Statut: ppublish

Résumé

With an increasingly dynamic global illicit drug market, including the emergence of novel psychoactive substances, many jurisdictions have moved to establish toxicosurveillance systems to enable timely detection of harmful substances in the community. This paper describes the methodology for the Emerging Drugs Network of Australia - Victoria (EDNAV) project, a clinical registry focused on the collection of high-quality clinical and analytical data from ED presentations involving illicit drug intoxications. Drug intelligence collected from the project is utilised by local health authorities with the aim to identify patterns of drug use and emerging drugs of concern. The project involves 10 public hospital EDs in Victoria, Australia. Patients 16 years and over, presenting to a network ED with a suspected illicit drug-related toxicity and a requirement for venepuncture are eligible for inclusion in the study under a waiver of consent. Clinical and demographic parameters are documented by site-based clinicians and comprehensive toxicological analysis is conducted on patient blood samples via specialised forensic services. All data are then deidentified and compiled in a project specific database. Cases are discussed in weekly multidisciplinary team meetings, with a view to identify potentially harmful substances circulating in the community. High-risk signals are escalated to key stakeholders to produce timely and proportionate public health alerts with a focus on harm minimisation. The EDNAV project represents the first centralised system providing near real-time monitoring of community drug use in Victoria and is fundamental in facilitating evidence-based public health intervention.

Identifiants

pubmed: 36053993
doi: 10.1111/1742-6723.14059
doi:

Substances chimiques

Illicit Drugs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

82-88

Subventions

Organisme : Department of Health and Human Services, State Government of Victoria
Organisme : Emerging Drugs Network of Australia study

Informations de copyright

© 2022 Australasian College for Emergency Medicine.

Références

Commonwealth of Australia Department of Health. National Framework for Alcohol, Tobacco and Other Drug Treatment 2019-29. Canberra: Commonwealth of Australia, 2019.
Commonwealth of Australia Department of the Prime Minister and Cabinet. Final Report of the National ice Taskforce. Canberra: Commonwealth of Australia, 2015.
Tracy DK, Wood DM, Baumeister D. Novel psychoactive substances: types, mechanisms of action, and effects. BMJ 2017; 356: i6848.
Coroners Court Of Victoria. Coroner Calls for Urgent Drug Testing Services in Victoria [Press Release]. Melbourne: Coroners Court of Victoria, 2021.
United Nations Office on Drugs and Crime Research and Trend Analysis Branch. COVID-19 and the Drug Supply Chain: From Production and Trafficking to Use. Vienna: United Nations Office on Drugs and Crime, 2020.
Peacock A, Price O, Karlsson A et al. Impact of COVID-19 and Associated Restrictions on People Who Inject Drugs in Australia: Findings from the Illicit Drug Reporting System 2020. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2020.
Sutherland R, Baillie G, Memedovic S et al. Key Findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT)’ Study Wave 3. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2021.
Coroners Court of Victoria. Victorian Overdose Deaths, 2011-2020. Melbourne: Coroners Court of Victoria, 2021.
United States Centres for Disease Control and Prevention. Increase in Fatal Drug Overdoses across the United States Driven by Synthetic Opioids before and during the COVID-19 Pandemic. Alanta: Centres for Disease Control Health Alert Nework, 2020.
Victoria Law Reform Road and Community Safety Committee. Inquiry into Drug Law Reform. Melbourne: Parliament of Victoria, 2018.
Australian Criminal Intelligence Commission. National Wastewater Drug Monitoring Program (NWDMP) - Report 12. Canberra: Australian Ciminal Intelligence Commission, 2021.
Wood DM, De La Rue L, Hosin AA et al. Poor identification of emergency department acute recreational drug toxicity presentations using routine hospital coding systems: the experience in Denmark, Switzerland and the UK. J. Med. Toxicol. 2019; 15: 112-20.
Stam NC, Gerostamoulos D, Pilgrim JL et al. An analysis of issues in the classification and reporting of heroin-related deaths. Addiction 2019; 114: 504-12.
Wilcox N, McNeil JJ. Clinical quality registries have the potential to drive improvements in the appropriateness of care. Med. J. Aust. 2016; 205: S27-9.
McCutcheon D, Raghavan M, Soderstrom J et al. An early warning system for emerging drugs of concern in the emergency department: protocol for the Western Australian Illicit Substance Evaluation (WISE) study. Emerg. Med. Australas. 2019; 31: 411-6.
Partridge E, Alfred S, Camilleri A et al. Establishing the protocols for the South Australian Emergency Department Admission Blood Psychoactive Testing (EDABPT) programme for drug surveillance. Emerg. Med. Australas. 2021; 33: 883-7.
The National Health and Medical Research Council. National statement on ethical conduct in human research 2007. Canberra: National Health and Medical Research Council, 2007 (Updated 2018); 116.
Harris PA, Taylor R, Minor BL et al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Inform. 2019; 95: 103208.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009; 42: 377-81.
Smith JL, Soderstrom J, Dawson A et al. The Emerging Drugs Network of Australia: a toxicosurveillance system of illicit and emerging drugs in the emergency department. Emerg. Med. Australas. 2022; 34: 58-64.
Scamvougeras A, Greene SL, Norman A, Bonomo Y, Castle DJ. The fentanyls: a ‘future threat’ for Australia? Australas. Psychiatry 2020; 28: 545-7.
Di Rago M, Pantatan S, Hargreaves M et al. High throughput detection of 327 drugs in blood by LC-MS-MS with automated data processing. J. Anal. Toxicol. 2021; 45: 154-83.
Department of Health Victoria. Drug alerts. Melbourne: Department of Health Victoria, 2021. Available from URL: https://www.health.vic.gov.au/alcohol-and-drugs/drug-alerts
European Monitoring Centre for Drugs and Drug Addiction. Risk Assessment of New Psychoactive Substances: Operating Guidelines. Luxembourg: Publications Office of the European Union, 2009.
Australian Institue of Health and Welfare. Emergency Department Care 2020-21: Australian Hospital Statistics [Data File]. Canberra: Commonwealth of Australia, 2021.
United Nations Office on Drugs and Crime. The Role of Drug Analysis Laboratories in Early Warning Systems. Vienna: United Nations Office on Drugs and Crime, Division for Policy Analysis and Public Affairs, 2020.
Camilleri A, Alfred S, Gerber C et al. Delivering harm reduction to the community and frontline medical practitioners through the South Australian Drug Early Warning System (SADEWS). Forensic Sci. Med. Pathol. 2021; 17: 388-94.
Ambulance Victoria. Hospital Catchments. Melbourne: Ambulance Victoria, 2021; 2 Figure 1.
Municipal Association of Victoria. Rural and Regional Councils Map. Melbourne: Municipal Association of Victoria, 2021.
World Health Organization. The WHO Stepwise Approach to Surveillance of Noncommunicable Diseases (STEPS). Geneva: World Health Organization, 2003.

Auteurs

Rebekka Syrjanen (R)

Victorian Institute of Forensic Medicine, Melbourne, Victoria, Australia.
Department of Forensic Medicine, Monash University, Melbourne, Victoria, Australia.

Jennifer Schumann (J)

Victorian Institute of Forensic Medicine, Melbourne, Victoria, Australia.
Department of Forensic Medicine, Monash University, Melbourne, Victoria, Australia.
Monash Addiction Research Centre, Monash University, Melbourne, Victoria, Australia.

John Fitzgerald (J)

Department of Criminology, School of Social and Political Sciences, Faculty of Arts, The University of Melbourne, Melbourne, Victoria, Australia.

Dimitri Gerostamoulos (D)

Victorian Institute of Forensic Medicine, Melbourne, Victoria, Australia.
Department of Forensic Medicine, Monash University, Melbourne, Victoria, Australia.

Rachelle Abouchedid (R)

Emergency Department, Bendigo Hospital, Bendigo Health, Bendigo, Victoria, Australia.
Victorian Poisons Information Centre, Austin Hospital, Austin Health, Melbourne, Victoria, Australia.

Joe-Anthony Rotella (JA)

Victorian Poisons Information Centre, Austin Hospital, Austin Health, Melbourne, Victoria, Australia.
Emergency Department, The Northern Hospital, Northern Health, Melbourne, Victoria, Australia.
Department of Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.

Jonathan Knott (J)

Department of Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
Emergency Department, The Royal Melbourne Hospital, Melbourne Health, Melbourne, Victoria, Australia.

Jacqueline Maplesden (J)

Emergency Department, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.

Hans Hollerer (H)

Emergency Department, Footscray Hospital, Western Health, Melbourne, Victoria, Australia.

Liam Hannon (L)

Emergency Department, Bendigo Hospital, Bendigo Health, Bendigo, Victoria, Australia.

Elyssia Bourke (E)

Department of Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
Emergency Department, Ballarat Base Hospital, Ballarat Health Services, Ballarat, Victoria, Australia.

Sarah E Hodgson (SE)

Victorian Poisons Information Centre, Austin Hospital, Austin Health, Melbourne, Victoria, Australia.
Emergency Department, Austin Hospital, Austin Health, Melbourne, Victoria, Australia.

Shaun L Greene (SL)

Victorian Poisons Information Centre, Austin Hospital, Austin Health, Melbourne, Victoria, Australia.
Department of Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
Emergency Department, Austin Hospital, Austin Health, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH